Clin2
NCT06850311Likely a fitRecruiting

Herbal ointment for mild to severe eczema

Atopic DermatitisAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaTCMSkin DiseasesSkin Diseases, EczematousSkin Diseases, Genetic

Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.

This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
66 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be between 18 and 65 years old.
  • Have atopic dermatitis (eczema) diagnosed by a doctor.
  • Your eczema covers less than 10% of your body.
  • Your eczema is rated as mild, moderate, or severe by a doctor.
  • Use a simple, fragrance-free moisturizer for at least 7 days before starting the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07629778Recruiting· Phase 1/Phase 2
HL-300 Ointment for Mild-to-Moderate Atopic Dermatitis

This study tests a new ointment (HL-300) designed to treat mild-to-moderate atopic dermatitis (a chronic skin condition causing itching and inflammation). You would apply it to affected skin areas to see if it safely reduces symptoms.

Hangzhou, Zhejiang
NCT06880276Recruiting· Phase 3
Studying QLM3003 ointment for mild or moderate eczema

This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.

Shenyang
NCT06487000Not yet recruiting· Phase 2
Testing EC-18 for moderate to severe eczema

This trial tests an experimental drug called EC-18 (a pill) for people with moderate to severe eczema that hasn't been controlled well with creams. It aims to see if different doses of the drug can safely reduce itching and skin rash.

NCT07592585Recruiting· Phase 3
Testing VC005 cream for mild-to-moderate eczema in teens and adults

This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.

Nanjing, Jiangsu
NCT04419584Recruiting· Phase 2/Phase 3
Modified Qing-Ying decoction for children with eczema

This trial tests a traditional Chinese herbal formula (Modified Qing-Ying Decoction) for children ages 4 to 17 with moderate-to-severe eczema (atopic dermatitis). The study aims to see if this herbal treatment can improve skin dryness, redness, and itching, especially for those with dry, scaly patches.

Hong Kong
NCT05575882Recruiting
Skin cream trial to prevent relapses in very dry eczema skin

This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.

Ciudad Autónoma de Buenos Aire, Ciudad Autónoma de Buenos Aire

Hear when a new Atopic Dermatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.